About

Amped PCR is a Deep Tech company developing PurifAI, a swab to dashboard molecular diagnostics platform that replaces century old culture testing with next day results using AI, qPCR and Nanopore sequencing.


PurifAI turns a simple swab into real time, actionable microbial data and intelligence that applied markets rely on, from food safety, veterinary, agriculture to water, energy, cosmetics and raw materials. These markets represent more than 60 billion dollars in global TAM and remain reliant on slow culture based diagnostics.

PurifAI is positioned to become the leading Diagnostics as a Service platform for applied market biosurveillance.

Management Team

Founded by Ben Davis and Aysha Shah.

Black and white digital illustration of a man with dark hair, a beard, and a mustache, wearing a dark-colored shirt.

  • Founder Ben Davis leads Amped PCR with over 15 years of experience driving innovation in the biotech industry.

    His proven ability to secure strategic partnerships and scale solutions from concept to commercialisation was critical to securing pre-seed investment for Amped PCR from the Development Bank of Wales (DBW) and SFC Capital, the UK’s leading SEIS/EIS fund managers.

    Ben's leadership has fostered collaborations with industry giants in Manufacturing, resulting in advancements across reagent design, cleanroom workflows, and data analytics.

    His prior experience at NuGEN Technologies, The Technology Partnership (TTP) and LGC Genomics includes leading multi-million-pound projects, developing rapid PCR formulations and co-developing PuckDX, a point-of-care qPCR platform now licensed to Diasorin.

Black and white minimalistic illustration of a woman with shoulder-length hair, looking slightly upwards.

  • Co-founder of Amped PCR, Aysha brings a unique blend of design innovation and comms expertise to the company's leadership.

    A graduate of The Cass School of Art, Architecture & Design, her award-winning product design background includes collaborations with prestigious brands like Heal's and recognition in the Financial Times.

    In comms, her press releases regularly featured in BBC News Online and other local, national, and global media outlets.

    Aysha leads the company's design philosophy, ensuring products combine cutting-edge functionality with intuitive user experience.

    As a neurodivergent founder with dyslexia and ADHD, Aysha brings a distinctive perspective to design and problem-solving.

    Instrumental in articulating the company's vision, she has contributed to successful funding rounds with DBW and SFC Capital.

Latest News & Achievements